Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CME | Common Stock Class A | Award | $16.6K | +75 | +0.71% | $221.79 | 10.7K | Jan 25, 2022 | by Trust | F1, F2 |
holding | CME | Common Stock Class A | 185 | Jan 25, 2022 | By Firm | F3 | |||||
holding | CME | Common Stock Class A | 0.375 | Jan 25, 2022 | by Partnership |
Id | Content |
---|---|
F1 | Granted pursuant to the CME Group Director Stock Plan, as amended and restated. |
F2 | The original Form 4 filed on January 26, 2022 incorrectly reported 4,719 shares held indirectly through Mr. Carey's Trust. This amendment is being filed to correctly report the amount as 10,675 shares held indirectly through Mr. Carey' Trust. |
F3 | The original Form 4 filed on January 26, 2022 incorrectly reported 6,141 shares that were previously held indirectly through Mr. Carey's firm. This amendment is being filed to correctly report the amount as 185 shares. |